News

TRIP vs. EBAY: Which Stock Is the Better Value Option?

BMY vs. AMGN: Which Stock Is the Better Value Option?

SIMO is expanding into AI infrastructure and enterprise SSD controllers as commercial production ramps and new customer deployments broaden its growth opportunities.

The acquisition, which was first announced in June, brings Vibe.co into Walmart Connect, Walmart's connected TV advertising platform.

SRX Global (AMEX:SRXH) disclosed an investment in Vistagen Therapeutics (NASDAQ:VTGN) and said it intends to engage with the company’s leadership and board on potential shareholder value initiatives. Key Investor TakeawaysSRX Global (AMEX:SRXH) acquired a stake in Vistagen Therapeutics (NASDAQ:VTGN).

Coca-Cola and PepsiCo are taking very different paths through the health-conscious-beverage boom, and one is pulling away in a big way.

Goldman Sachs just handed Microsoft its most coveted endorsement while cutting three other tech giants loose, and the reasoning behind that trade reveals exactly where Wall Street thinks the AI money flows next.

Alternative asset manager Ares Management (NYSE:ARES) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 25.6% year on year to $1.28 billion. Its non-GAAP profit of $1.29 per share was 1.4% above analysts’ consensus estimates.

While Morgan Stanley has outpaced the broader market over the past year, Wall Street analysts maintain a cautiously optimistic outlook about the stock’s prospects.

BWXT raises its 2026 outlook as stronger operations support higher guidance, while a medical divestiture and PCG deal sharpen its nuclear focus.

Amazon just crossed a milestone that puts it in rare company, but the real question is whether the forces driving that surge can hold through year-end or whether a $200 billion spending gamble quietly undermines everything.

Asset managers are doing an about face on outsourcing, seeking to bring more functions in-house. A combo of factors has created an opportunity in muni bond investing. These are among investment must reads for financial advisors this week.

Decent Holding (NASDAQ:DXST) reported sharply higher first-half revenue driven by wastewater treatment projects and the launch of its AI-powered Suncare senior healthcare platform, while increased expansion costs weighed on earnings. Key Investor TakeawaysDecent Holding (NASDAQ:DXST) reported first-half fiscal 2026 revenue of $18.

The US dollar (DX-Y.NYB) has weakened after the US and Japan jointly intervened to boost the yen. Yahoo Finance Markets and Data Editor Jared Blikre takes a closer look at the dollar's decline and the yen's growing strength, comparing it to prior events in the yen's history.

Investors are increasingly concerned that AI spending won't pay off.

Ark Invest added to three existing positions on Monday, with two of them still trading for half of last year's peak.

Integrated energy company Chevron (NYSE:CVX) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 56.3% year on year to $70.06 billion. Its non-GAAP profit of $6.06 per share was 8.8% above analysts’ consensus estimates.

XOM's Q2 earnings missed estimates, but strong production, oil prices and balance sheet strength support its outlook.

Bruker (NASDAQ:BRKR) returned to organic revenue growth in the second quarter, posted stronger bookings across its Scientific Instruments business, and maintained its earnings outlook while adjusting guidance for currency and tax changes. Key Investor TakeawaysBruker (NASDAQ:BRKR) returned to organic revenue growth, with second-quarter revenue increasing 5.

Dan Ives thinks the AI spending wave has barely started, and the hyperscalers are finally proving the skeptics wrong. The question now is which stocks stand to benefit most before the rest of the market catches on.

Pfizer lifted its 2026 revenue forecast by $500 million at the midpoint.

IRDM's Aireon deal adds at least $100 million in annual service revenue, but new debt, integration demands and Rocket Lab uncertainty raise the stakes.

Uber is expected to deliver another quarter of robust growth, driven by continued strength in its Mobility and Delivery businesses.

An analysis of the last seven years of Tesla earnings calls shows just little attention Musk pays to Tesla's car business.

Baron Capital, an investment management company, released its Q2 2026 investor letter for the “Baron Health Care Fund”. A copy of the letter is available to download here. The Fund gained 11.99% during the quarter, compared with the 10.48% gain for the Russell 3000 Health Care Index and the 15.44% gain for the Russell 3000 Index. Since inception, […]

NRG's Q2 earnings miss estimates, but revenues climb 11% as lower operating costs and shareholder returns support performance.

Bristol Myers Squibb's (BMY) reported merger discussions with AstraZeneca (AZN) will unlikely result

SpaceX received about 20% of its 2025 revenue from U.S. federal agencies.

Free cash flow is negative while the cloud build runs, and that is the whole question for anyone weighing the stock today.

Investors need to pay close attention to AAL stock based on the movements in the options market lately.